Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-18-044788

Options or other derivatives

  • Chief Medical Officer acquired 35,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Levy Howard · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-07-30 Grant or award : show line 1 in the form Stock Option (Right to Buy) +35,000 $9.68 2028-07-30 35,000 35,000 D
Loading xslF345X03/doc4.xml…